Hester Biosciences Q2 Profit Doubles on Strong Sales
Hester Biosciences reported a two-fold jump in Q2 profit driven by higher divisional product sales, with revenue rising by 19 percent. Animal healthcare and poultry healthcare segments saw strong growth.
Mumbai, Oct 28 (PTI) Leading animal health products manufacturer Hester Biosciences on Monday said its net profit jumped two-fold jump in the July-September quarter driven by higher divisional product sales.
The consolidated profit after tax of the company doubled to Rs 8.39 crore in the September quarter compared to Rs 4.04 crore in the year-ago period, according to an exchange filing by the company.
Consolidated revenue from operations rose by 19 per cent to Rs 83.69 crore in the second quarter of FY25 from Rs 70.45 crore a year ago.
Animal healthcare segment revenue rises 4 per cent to Rs 31.67 crore, and poultry healthcare revenue by 20 per cent to Rs 40.77 crore.
The strong domestic demand for milk and dairy products continued into Q2, further boosting sales within the dairy sector, the filing said.
The consolidated profit after tax of the company doubled to Rs 8.39 crore in the September quarter compared to Rs 4.04 crore in the year-ago period, according to an exchange filing by the company.
Consolidated revenue from operations rose by 19 per cent to Rs 83.69 crore in the second quarter of FY25 from Rs 70.45 crore a year ago.
Animal healthcare segment revenue rises 4 per cent to Rs 31.67 crore, and poultry healthcare revenue by 20 per cent to Rs 40.77 crore.
The strong domestic demand for milk and dairy products continued into Q2, further boosting sales within the dairy sector, the filing said.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 6.65 (+ 1.53)
- 49454757
- Harshil Agrotech
- 2.45 (+ 4.26)
- 24131089
- AvanceTechnologies
- 0.88 (+ 11.39)
- 23637747
- KPR Mill Ltd.
- 1,178.85 ( -4.17)
- 11441669
- Standard Capital
- 0.37 ( 0.00)
- 10479485
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback